11.08.2013 Views

ÊÀ Ò Ã É Ï Ë Ï Â ÉÀ - sppf.info

ÊÀ Ò Ã É Ï Ë Ï Â ÉÀ - sppf.info

ÊÀ Ò Ã É Ï Ë Ï Â ÉÀ - sppf.info

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

,fdidsf rfhlbjkjubf<br />

saqarTvelos bavSvTa kardiologTa asociacia ............................................................................................................................................................ 6<br />

Georgian Pediatric Cardiology Association .............................................................................................................................................................................. 9<br />

kardiologia<br />

ST seg men ti sa da T kbi lis cvli le ba ni jan m r Tel bav S v Ta sxva das x va asa kob riv jgu feb Si<br />

ST and T wa ve chan ges in chil d ren of dif fe rent ages ......................................................................................................................................................... 11<br />

sportsmenTa fizikuri da funqciuri mdgomareobis Sefaseba apipulmosa da apikoris fonze<br />

Estimation of sportsmen physical and functional condition under the treatment of Apipulmo and Apicori .................................... 19<br />

e.k.g.-is (ST da T kbili) da kapilaroskopiuli parametrebi bavSvebSi diabetis pirveli tipis dros.<br />

EKG Parameters ( ST and T wave ) and Capillaroscopic Parameters during Diabetes Mellitus Type I in Children ..................................... 23<br />

e.k.g. pa ra met re bi (ST seg men ti da T kbi li) Saq ri a ni di a be tis ti pi I - sa, zo gi er Ti an Te ba di da sxva<br />

ara an Te ba di da a va de be bis dros bav S v Ta asak Si<br />

EKG Parameters (ST and T wa ve) du ring Diabetes Mellitus Type I in Chil d ren du ring so me in f lam ma tory and<br />

non-in f lam ma tory di se a ses ............................................................................................................................................................................................................... 26<br />

mit ra lu ri sar q v lis pro lap sis six Si re, eti o pa To ge ne zi, da a va de ba Ta pa To ge nur pro ces Si Cab mis xa -<br />

ris xis gan sazR v ra da ari aT mi eb Tan kon teq s Si mi si gan xil va<br />

The fre qu ency of mit ral val ve pro lap se, et hi o logy and pat ho logy, de ter mi na ti on of pat ho lo gi cal pro cess in vol ve ment deg ree<br />

and dis cus si on in con text with Arrhythmia .............................................................................................................................................................................................. 32<br />

ST seg men ti sa da T kbi lis cvli le be ba Ta Rrma kli ni ku ri ana li zis auci leb lo ba, par kuW Ta re po la -<br />

ri za ci is, na ad re vi ag z ne bis par ci a lu ri sin d rom Ta da P-Q in ter va lis Sem ci re bis ar se bo bi sas bav S v -<br />

Ta da mo zar d Ta asak Si<br />

Clinical value of ST segment and T wave, during ventricle repolarization, early discharge partial syndrome and<br />

narrowed P-Q interval in children and adolescents ........................................................................................................................................................... 38<br />

arteriuli hipertenzia bavSvTa da mozardTa asakSi<br />

Arterial hypertension in children and adult ...................................................................................................................................................................... 41<br />

gu lis riT mi sa da gam ta ro bis dar R ve va bav S v Ta asak Si (ma Ti mar T vis Ta na med ro ve prin ci pe bi)<br />

Heart rhythm and con duc ting di sor der in chil d ren (Modern go ver ning prin cip les) .............................................................................. 48<br />

revmatologia<br />

ki dev er Txel mwva ve rev ma ti u li cxe le bis Se sa xeb<br />

Once aga in abo ut acu te rhe u ma tic fe ver ............................................................................................................................................................................. 57<br />

rev ma to lo gi i sa da ar T ro lo gi is sa kiTxe bi<br />

Questions of rhe u ma to logy and ar t h ro logy ............................................................................................................................................................................. 64<br />

kodebi revmatologiaSi ........................................................................................................................................................................................................ 69<br />

sxvadasxva<br />

pe di at ri ul kar di o lo gi a Si – in feq ci ur pa To lo gi a Ta dros mkur na lo ba Si imu no Te ra pi u li pre pa rat<br />

“GA-40”-is Car T vis Se saZ leb lo ba ni<br />

In pe di at ric car di o logy - pos sib le usa ge of Immune the ra pe u tic me di ci ne “GA-40” in tre at ment du ring in fec ti o us pat ho logy ... 77<br />

spor tu li va le o lo gi is gan vi Ta re bis per s peq ti ve bi<br />

Перспективы развития спортивной валеологии The prospects of sporting valeology ........................................................................... 79<br />

saintereso SromaTa kaleidoskopi<br />

Факторы риска поражения сердечно-сосудистой системы при ревматоидном артрите и системной красной волчанке<br />

у детей; клинико-инструментальный (эхокардиографический) анализ ранних морфофункциональных проявлений<br />

заболевания, вопросы профилактики и реабилитации автореферат диссертации для написания диплома,<br />

курсовой работы, тема для доклада и реферата ............................................................................................................................................................................ 82<br />

zo gi er Ti Tan da yo li li, an Te ba di da Se Ze ni li ara an Te ba di da a va de bis dros gul-sis x l Zar R v Ta<br />

sis te mis kli ni kur-in s t ru men tu li da xa si a Te ba bav S v Ta asak Si da mkur na lo ba Si pre pa rat GA-40-is<br />

Car T vis Se saZ leb lo ba ni ............................................................................................................................................................................................................ 85<br />

Clinical-instrumental characterizations of Cardiovascular System during Some Congenital, inflammatory and acquired<br />

noninflammatory diseases in Childhood and possibilities of The involvement of preparation GA-40 in The TReatment.............................. 87<br />

aTerosklerozis risk-faqtorebi msuqan bavSvebSi ..................................................................................................................................................................................... 88<br />

Atherosclerosis Risk-Factors in Obese Chil d ren ................................................................................................................................................................. 89<br />

praq ti ko si eqi me bi saT vis<br />

da a va de ba Ta mar T vis erov nu li pro to ko li ................................................................................................................................................... 90<br />

Teoriuli safuZvlebi .......................................................................................................................................................................................................... 102<br />

2013 weli<br />

sarCevi CONTENTS<br />

3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!